Autopsy report · NCT04892446

Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

“This study was terminated early due to the Sponsor's decision to discontinue development of the investigational drug and close the program.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 36 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Gilead Sciences

Sponsor type

Industry

Conditions

Multiple Myeloma

Interventions

Magrolimab; Daratumumab; Pomalidomide; Dexamethasone; Bortezomib; Carfilzomib

Participants

36

Sites

22

Countries

Canada, Czechia, United States

Trials that died the same way

• Panobinostat/Velcade in Multiple Myeloma
  “This study was terminated because the drug company stopped making the study drug” (85% match in meaning)
• Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
  “The study was terminated due to the sponsor's decision to discontinue the clinical trial.” (84% match in meaning)
• An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
  “The study was terminated early due to sponsor decision unrelated to safety or efficacy findings” (84% match in meaning)
• Study of Satraplatin (JM-216) in Combination With Docetaxel
  “Sponsor decided to discontinue study drug development.” (84% match in meaning)
• Liver Transplantation With Tregs at UCSF
  “The study was terminated by the Sponsor prior to any participants receiving the investigational product.” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.